Rynki

Twoje finanse

Biznes

Forum

SOPHARMA AD: Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

Spis treści:

1. REPORT

reklama

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Donev investments holding Sopharma EN 2025.09.04Sell.pdf  (REPORT)

przewiń, aby zobaczyć całą tabelę
POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 142 / 2025
Date of issue: 2025-09-05
Short name of the issuer
SOPHARMA AD
Subject
Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
Official market - legal basis
Art. 56. 1. 2 of Act on Public Offering
Unofficial market - legal basis
Contents of the report:
Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD
Annexes
File Description
Donev investments holding Sopharma EN 2025.09.04Sell.pdfDonev investments holding_Sopharma_EN_2025.09.04Sell.pdf Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD

przewiń, aby zobaczyć całą tabelę
SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

przewiń, aby zobaczyć całą tabelę
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-09-05 Ognian Donev Executive Director
Źródło: Komunikaty spółek (ESPI)
powiązane
polecane
najnowsze
popularne
najnowsze
bankier na skróty